病因对癫痫持续状态患者死亡与神经功能恢复的影响
这项两中心观察性研究纳入2015至2023年间巴塞尔和日内瓦大学医院收治的967例成人癫痫持续状态患者,按ILAE分类评估病因与结局的关联。调整混杂因素和生命维持治疗撤除后,病因与神经功能恢复相关,但与短期死亡率无关;伴昏迷的非惊厥性癫痫持续状态与不良结局关联最强。
要点
- 病因与神经功能恢复相关,颅内出血和急性症状性SE恢复可能性降低。
- 已知癫痫病因者恢复至病前功能的可能性增加。
- 伴昏迷的非惊厥性SE是生存的最关键决定因素。
核心结论
- 调整混杂因素和WLST后,病因与神经功能恢复相关,但与短期死亡率无关。
- 伴昏迷的NCSE与不良结局关联最强,是比病因更关键的生存决定因素。
研究设计与样本
- 两中心观察性研究,纳入2015至2023年巴塞尔和日内瓦大学医院≥18岁SE成人患者967例。
- 病因按ILAE分类为急性症状性、远期症状性-非诱发性、进行性CNS疾病、无额外诱因的癫痫、隐源性。
- 采用Poisson回归(稳健误差方差),调整年龄、伴昏迷的NCSE、合并症和中心。
主要发现
- 967例患者中位年龄67岁(IQR 54-78),女性46.5%,SE终止率95%。
- 急性症状性SE占34.2%,远期症状性SE占27.6%,进行性CNS疾病占14.4%,无额外诱因的癫痫占16.7%,隐源性占7.1%。
- 院内死亡率和30天死亡率分别为7.9%和13.9%,48.5%恢复至病前功能。
- 颅内出血(RR 0.49,95%CI 0.35-0.67)和急性症状性SE(RR 0.71,95%CI 0.60-0.83)与恢复可能性降低相关;已知癫痫与恢复可能性增加相关(RR 1.40,95%CI 1.23-1.60)。
- 伴昏迷的NCSE(11.9%)与更高的院内和30天死亡率及所有ILAE病因组中恢复降低独立相关。
临床怎么用
- 预后评估中应重视SE类型,尤其是伴昏迷的NCSE对生存的强关联。
- 病因可用于判断神经功能恢复前景,但不能单独决定短期生存预后。
局限性
- 观察性设计可能残留混杂。
- 仅纳入两中心患者,外推性受限。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND OBJECTIVES: Although etiology is considered central to outcomes in status epilepticus (SE), previous studies often lacked standardized classification and adjustment for confounders, particularly withdrawal of life-sustaining treatment (WLST). This study examined the association between SE etiology, mortality, and neurologic recovery using the International League Against Epilepsy (ILAE) classification while accounting for confounders and WLST. METHODS: This 2-center observational study included adults (≥18 years) with SE treated at the University Hospitals of Basel and Geneva from 2015 to 2023. Etiologies were classified as acute symptomatic, remote symptomatic-unprovoked, progressive CNS disorders, epilepsy without additional triggers, or cryptogenic. Demographics, SE type, SE severity score, Charlson Comorbidity Index, treatment data, complications, and WLST were assessed. The primary outcome was in-hospital mortality; secondary outcomes were 30-day mortality and recovery to premorbid neurologic function at discharge. Associations were assessed using Poisson regression with robust error variance, adjusted for age, nonconvulsive SE (NCSE) with coma, comorbidity, and center. RESULTS: Among 967 patients (median age 67 years, interquartile range 54-78; 46.5% female), SE was terminated in 95%, with 48.5% of patients recovering to premorbid function. Acute symptomatic SE accounted for 34.2%, remote symptomatic SE for 27.6%, SE due to progressive CNS disorders for 14.4%, epilepsy without additional triggers for 16.7%, and cryptogenic SE for 7.1%. In-hospital and 30-day mortality were 7.9% and 13.9%, respectively, while 48.5% recovered to premorbid function. Etiology was associated with neurologic recovery, with intracranial hemorrhage (relative risk [RR] 0.49, 95% CI 0.35-0.67) and acute symptomatic SE (RR 0.71, 95% CI 0.60-0.83) being associated with reduced likelihood of recovery, whereas known epilepsy was associated with increased likelihood of recovery (RR 1.40, 95% CI 1.23-1.60). NCSE with coma (11.9%) was independently associated with higher in-hospital and 30-day mortality and reduced recovery across all ILAE etiology groups. WLST did not significantly alter these associations. DISCUSSION: Etiology was associated with neurologic recovery but not with short-term mortality after adjustment for confounders and WLST. By contrast, NCSE with coma showed the strongest association with adverse outcomes. This suggests that while etiology informs prognosis for recovery, SE type, particularly NCSE with coma, is the more critical determinant of survival.
引用
- De Stefano P, Baumann SM, Fisch U, et al. Impact of Etiology on Mortality and Recovery in Patients With Status Epilepticus. Neurology. 2026. PMID: 41637681. doi:10.1212/WNL.0000000000214624
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。